is tirzepatide used for weight loss a Game-Changer in Medical Treatment? Semaglutide vs. Tirzepatide for Weight

GLP-1RAs may enhance fertility and manage polycystic ovary syndrome

Who qualifies: Generally BMI 30, or 27 with weight-related conditions (e.g., hypertension, insulin resistance)

But after clinical trails showed its promising effects on weight loss, in 2021, the FDA approved semaglutide (Wegovy), a once-weekly injection, for weight loss in adults when used in combination with a healthy diet and routine exercise

Additional information Managed by Massimo Federici

Participants received once-weekly semaglutide (initiated at 0.25 mg and gradually escalated to 2.0 mg) for 12 weeks, along with lifestyle intervention

doi:10.14309/crj.0000000000001551 BDS, MDS Dr.Niharika Harsha B (BDS,MDS) completed her BDS from Govt Dental College, Hyderabad and MDS from Dr.NTR University of health sciences(Now Kaloji Rao University)